Curexo Inc. (KOSDAQ:060280)
South Korea · Delayed Price · Currency is KRW 18,300
-1,350 (-6.87%)
At close: Feb 6, 2026
Curexo Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|
Period Ending | Sep '16 Sep 30, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
Operating Revenue | 27,848 | 27,530 | 26,138 | 31,091 | 24,281 | 10,542 |
Other Revenue | 0 | 0 | 0 | - | - | - |
| 27,848 | 27,530 | 26,138 | 31,091 | 24,281 | 10,542 | |
Revenue Growth (YoY) | -3.00% | 5.33% | -15.93% | 28.05% | 130.32% | -67.21% |
Cost of Revenue | 25,146 | 25,125 | 22,775 | 27,188 | 21,726 | 5,601 |
Gross Profit | 2,702 | 2,404 | 3,363 | 3,903 | 2,555 | 4,941 |
Selling, General & Admin | 24,001 | 18,948 | 11,620 | 8,521 | 8,443 | 7,655 |
Research & Development | 19,666 | 7,559 | 11,929 | 7,858 | 4,393 | 2,859 |
Amortization of Goodwill & Intangibles | 1,358 | 324.43 | 83.17 | 89.32 | 155.46 | 738.7 |
Other Operating Expenses | 86.5 | 92.61 | 51.34 | 49.84 | 254.97 | 41.83 |
Operating Expenses | 45,282 | 27,163 | 24,096 | 17,944 | 16,702 | 12,306 |
Operating Income | -42,580 | -24,759 | -20,733 | -14,041 | -14,147 | -7,365 |
Interest Expense | -373.87 | -136.35 | -811.2 | -77.96 | -2,825 | -2,217 |
Interest & Investment Income | 66.15 | 76.68 | 94.7 | 80.62 | 827.82 | 873.93 |
Earnings From Equity Investments | - | - | - | -466.32 | -12.67 | -164.99 |
Currency Exchange Gain (Loss) | 5.53 | 18.25 | 42.15 | -23.92 | 3.76 | -29.13 |
Other Non Operating Income (Expenses) | 94.3 | -221.77 | -662.86 | -66.9 | -145.98 | 334.24 |
EBT Excluding Unusual Items | -42,788 | -25,022 | -22,070 | -14,595 | -16,299 | -8,568 |
Gain (Loss) on Sale of Assets | 2.55 | 6.18 | - | 1.1 | 755.19 | 2,298 |
Asset Writedown | - | - | -196.76 | - | -1,368 | -4,135 |
Other Unusual Items | - | - | - | - | -14.79 | -32.48 |
Pretax Income | -42,785 | -25,016 | -22,267 | -14,594 | -16,927 | -10,438 |
Income Tax Expense | 5.33 | 0.91 | 0.84 | 0.88 | - | 11.34 |
Earnings From Continuing Operations | -42,791 | -25,017 | -22,267 | -14,595 | -16,927 | -10,450 |
Earnings From Discontinued Operations | - | - | - | - | -1,315 | -179.11 |
Net Income to Company | -42,791 | -25,017 | -22,267 | -14,595 | -18,242 | -10,629 |
Minority Interest in Earnings | 26,644 | 15,614 | 11,408 | 7,130 | 5,191 | 6,631 |
Net Income | -16,147 | -9,402 | -10,859 | -7,465 | -13,051 | -3,998 |
Net Income to Common | -16,147 | -9,402 | -10,859 | -7,465 | -13,051 | -3,998 |
Shares Outstanding (Basic) | 27 | 27 | 27 | 27 | 24 | 21 |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 24 | 21 |
Shares Change (YoY) | -0.21% | -0.03% | 0.18% | 8.90% | 14.90% | 6.30% |
EPS (Basic) | -607.62 | -353.39 | -408.00 | -281.00 | -535.00 | -188.30 |
EPS (Diluted) | -607.62 | -353.39 | -408.00 | -281.00 | -535.00 | -188.30 |
Free Cash Flow | -42,611 | -22,843 | -22,141 | -15,396 | -20,974 | -11,759 |
Free Cash Flow Per Share | -1603.47 | -858.56 | -831.90 | -579.53 | -859.79 | -553.83 |
Gross Margin | 9.70% | 8.73% | 12.87% | 12.55% | 10.52% | 46.87% |
Operating Margin | -152.90% | -89.94% | -79.32% | -45.16% | -58.26% | -69.86% |
Profit Margin | -57.98% | -34.15% | -41.55% | -24.01% | -53.75% | -37.92% |
Free Cash Flow Margin | -153.01% | -82.98% | -84.71% | -49.52% | -86.38% | -111.54% |
EBITDA | -39,238 | -22,851 | -19,451 | -13,249 | -13,555 | -6,017 |
EBITDA Margin | -140.90% | -83.01% | -74.42% | -42.61% | -55.83% | -57.07% |
D&A For EBITDA | 3,342 | 1,908 | 1,281 | 792.07 | 591.94 | 1,349 |
EBIT | -42,580 | -24,759 | -20,733 | -14,041 | -14,147 | -7,365 |
EBIT Margin | -152.90% | -89.94% | -79.32% | -45.16% | -58.26% | -69.86% |
Advertising Expenses | - | 229.67 | 303.9 | 51.09 | 264.16 | 241.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.